US Broker Ratings

Biogen Inc. (BIIB) Stock Report: Analyst Ratings Signal Potential Upside of Over 8%

Biogen Inc. (NASDAQ: BIIB), a prominent player in the healthcare sector, stands as a beacon in the general drug manufacturing industry, boasting a robust market capitalization..

Teva Pharmaceutical Industries (TEVA): Investor Outlook with a 13.61% Potential Upside

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a stalwart in the healthcare sector, stands as a beacon for investors seeking exposure to the robust yet volatile world..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Assessing a Potential 107.71% Upside in Biotech

Summit Therapeutics Inc. (NASDAQ: SMMT) is carving its niche in the biotechnology sector with a focus on developing innovative therapies, including its lead candidate, ivonescimab, targeting..

DexCom, Inc. (DXCM) Stock Analysis: Strong Buy Ratings and a Promising 3.63% Upside

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector specializing in medical devices, has been making significant waves with its innovative continuous glucose monitoring (CGM)..

Natera, Inc. (NTRA) Stock Analysis: A Healthcare Powerhouse with a 3.21% Upside Potential

Natera, Inc. (NASDAQ: NTRA), a leading player in the Healthcare sector’s Diagnostics & Research industry, has been making headlines with its cutting-edge molecular testing services. With..

Boston Scientific Corporation (BSX) Investor Outlook: Impressive 33.84% Potential Upside Amid Strong Buy Ratings

Boston Scientific Corporation (BSX), a stalwart in the medical devices industry, continues to capture investor interest with its robust market position and promising growth prospects. With..

STERIS plc (STE) Stock Analysis: Understanding the 12.55% Upside Potential

Investors looking for robust opportunities in the healthcare sector might find STERIS plc (NYSE: STE) an intriguing prospect. With a market capitalization of $22.79 billion, STERIS..

Merck & Company, Inc. (MRK) Stock Analysis: Is the Current Valuation Justified for Investors?

Merck & Company, Inc. (NYSE: MRK) stands as a formidable entity in the healthcare sector, specifically within the general drug manufacturing industry. With a market capitalization..

Alcon Inc. (ALC) Stock Analysis: A Closer Look at Its 18.37% Potential Upside

Alcon Inc. (NYSE: ALC), a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry, continues to capture investor attention with its..

argenx SE (ARGX) Investor Outlook: Analyzing the 14.89% Potential Upside in Biotechnology

In the dynamic world of biotechnology, argenx SE (NASDAQ: ARGX) stands as a formidable player, captivating investor attention with its promising growth prospects and impressive market..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 13.86% Potential Upside for Investors

As the healthcare industry continues to evolve, Elevance Health, Inc. (NYSE: ELV) stands out as a significant player in the healthcare plans sector. With a market..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Navigating a 25.93% Upside Potential in the Healthcare Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $43.72..

Centene Corporation (CNC) Stock Analysis: Navigating a 10.68% Potential Upside in Healthcare

Centene Corporation (NYSE: CNC), a prominent player in the healthcare sector, is capturing the attention of investors with its substantial market presence and growth potential. With..

The Cigna Group (CI) Stock Analysis: Exploring a 22.42% Potential Upside and Strong Buy Ratings

The Cigna Group (NYSE: CI), an established name in the healthcare plans industry, presents a compelling opportunity for investors seeking exposure to the healthcare sector. With..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: A Closer Look at Its 28.29% Potential Upside

Intuitive Surgical, Inc. (NASDAQ: ISRG), a leader in the healthcare sector specializing in medical instruments and supplies, currently stands as a significant player with a robust..

Zoetis Inc. (ZTS)

⚠️ No article content returned.

..

Edwards Lifesciences Corporation (EW): Investor Outlook Highlights 11.92% Potential Upside

Edwards Lifesciences Corporation (NYSE: EW), a stalwart in the medical devices industry, continues to capture investor attention with its innovative cardiovascular solutions and promising growth prospects...

Cardinal Health, Inc. (CAH)

⚠️ No article content returned.

..

Alnylam Pharmaceuticals (ALNY) Investor Outlook: Exploring a 56% Potential Upside in Biotech Innovation

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnology sector, presents a compelling investment narrative for those keen on healthcare innovation. With a market capitalization..

Sanofi (SNY) Stock Analysis: A Healthcare Giant with 19.86% Upside Potential and a Robust Dividend Yield

Sanofi (SNY), a leading player in the global healthcare sector, presents a compelling opportunity for investors seeking both growth and income. As a French-based pharmaceutical giant..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds